Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Health and Human Services (HHS)
Research
NIH grants generated a 250% return on $36.6B investment in 2025
Funding delays and NIH turmoil preceded a total economic impact reduction of $430 million compared to 2024.
Will Maddox
Mar 11, 2026 11:11am
Fierce Pharma
FDA approves leucovorin without clinical trial—but not for autism
Mar 10, 2026 9:00am
HHS bans Anthropic's Claude AI tool
Mar 2, 2026 5:17pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
Fierce Healthcare
NIH Director Jay Bhattacharya to take over as temporary CDC head
Feb 18, 2026 4:30pm
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am